Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 1;28(6):1778-1799.
doi: 10.1212/CON.0000000000001183.

Muscle Channelopathies

Jaya R Trivedi
Review

Muscle Channelopathies

Jaya R Trivedi. Continuum (Minneap Minn). .

Abstract

Purpose of review: This article describes the clinical features, diagnosis, pathophysiology, and management of nondystrophic myotonia and periodic paralysis.

Recent findings: An increasing awareness exists about the genotype-phenotype overlap in skeletal muscle channelopathies, and thus genetic testing is needed to make a definitive diagnosis. Electrodiagnostic testing in channelopathies is highly specialized with significant overlap in various mutation subtypes. Randomized clinical trials have now been conducted in these disorders with expanded treatment options for patients with muscle channelopathies.

Summary: Skeletal muscle channelopathies are rare heterogeneous conditions characterized by lifelong symptoms that require a comprehensive management plan that includes pharmacologic and nonpharmacologic interventions. The significant variability in biophysical features of various mutations, coupled with the difficulties of performing clinical trials in rare diseases, makes it challenging to design and implement treatment trials for muscle channelopathies.

PubMed Disclaimer

References

    1. Raja Rayan DL, Hanna MG. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol 2010;23(5):466–476. doi:10.1097/WCO.0b013e32833cc97e - DOI
    1. Statland JM, Barohn RJ. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses. Continuum (Minneap Minn) 2013;19(6 Muscle Disease):1598–1614. doi:10.1212/01.CON.0000440661.49298.c8 - DOI
    1. Paninka RM, Carlos-Lima E, Lindsey SC, et al. Down-regulation of Kir2.6 channel by c-termini mutation D252N and its association with the susceptibility to thyrotoxic periodic paralysis. Neuroscience 2017;346:197–202. doi:10.1016/j.neuroscience.2017.01.019 - DOI
    1. Cannon SC. Pathomechanisms in channelopathies of skeletal muscle and brain. Annu Rev Neurosci 2006;29:387–415. doi:10.1146/annurev.neuro.29.051605.112815 - DOI
    1. Stunnenberg BC, LoRusso S, Arnold WD, et al. Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle Nerve 2020;62(4):430–444. doi:10.1002/mus.26887 - DOI

LinkOut - more resources